SK Capital, a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has entered into exclusive negotiations with France-based Euronext listed Lisi Group to acquire its Medical division (Lisi Medical).
Lisi Medical is a leading MedTech CDMO focused on the production of high-precision metal components and assemblies serving global medical device OEMs. Its products include instruments utilized in minimally invasive and robotic-assisted surgery as well as orthopaedic implants.
“Given Lisi Medical’s highly engineered solutions and deep relationships with leading MedTech customers, the company fits very well within the SK Capital portfolio,” said Aaron Davenport, managing director at SK Capital. “SK Capital has deep experience in the life sciences CDMO sector.”
Lisi Medical operates four manufacturing sites with expertise in precision machining, forging, and engineering solutions, including highly automated production – two in Minnesota and two in France.
“After 14 years of strong development and manufacturing consolidation within Lisi Group, we are now looking forward to partner with SK Capital and boost Lisi Medical’s next development phase,” said Emmanuel Viellard, CEO of Lisi Group.
The proposed transaction will allow Lisi Medical to benefit from SK Capital’s support in the deployment of its strategy, both in terms of organic growth and acquisitions. Lisi Group plans to take a stake of around 10% in the capital of the holding company.
“Under Lisi Group’s ownership, the Lisi Medical has made significant investments to increase automation, expand production capacity, and add capabilities to support the growth of its customers,” said Josh Lieberman, principal at SK Capital. “We look forward to working with Lisi Medical’s management team to accelerate the company’s growth by expanding with existing and new customers and continuing to add new capabilities both organically and through M&A.”
Lisi Medical accounted for 10% of the group’s total €1.79bn sales revenues in 2024.
Lisi Group shares are €40.40. They began the year at €22.10.
Kirkland & Ellis is serving as legal counsel and Piper Sandler, Jefferies, and Sycomore Corporate Finance are serving as financial advisors to SK Capital. Partners Group, acting on behalf of its clients, provided committed debt financing in support of the transaction.
Rothschild & Co is serving as financial advisor and Dentons is serving as legal counsel to Lisi Group.
Press release: LISI GROUP – Link Solutions for Industry – Fastener components for assembly in aeronautics, automotive